A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors,in combination with everolimus and as a single agent in an ovarian cancer expansion cohort 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors,in combination with everolimus and as a single agent in an ovarian cancer expansion cohort

摘要：
本文献已被 SpringerLink 等数据库收录！